Dean Capital Investments Management LLC boosted its stake in shares of Cooper Companies Inc (NYSE:COO) by 25.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,590 shares of the medical device company’s stock after acquiring an additional 324 shares during the period. Dean Capital Investments Management LLC’s holdings in Cooper Companies were worth $472,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ossiam purchased a new position in Cooper Companies during the 2nd quarter valued at approximately $25,000. Flagship Harbor Advisors LLC boosted its position in shares of Cooper Companies by 62.5% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 30 shares during the last quarter. Kings Point Capital Management purchased a new position in shares of Cooper Companies in the second quarter valued at $27,000. NumerixS Investment Technologies Inc purchased a new position in shares of Cooper Companies in the second quarter valued at $34,000. Finally, Evolution Wealth Advisors LLC bought a new stake in Cooper Companies in the second quarter worth $34,000. Institutional investors own 94.42% of the company’s stock.
A number of equities research analysts recently issued reports on COO shares. ValuEngine downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Tuesday, September 10th. Raymond James reaffirmed a “buy” rating on shares of Cooper Companies in a report on Monday, August 26th. KeyCorp decreased their price objective on Cooper Companies from $351.00 to $348.00 and set an “overweight” rating on the stock in a research report on Friday, October 11th. Piper Jaffray Companies set a $360.00 price objective on Cooper Companies and gave the company a “buy” rating in a research note on Friday, August 30th. Finally, Wells Fargo & Co lifted their target price on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have issued a buy rating to the stock. Cooper Companies presently has an average rating of “Buy” and an average price target of $326.00.
Shares of NYSE:COO traded up $1.89 during trading hours on Wednesday, hitting $296.42. 7,178 shares of the company’s stock traded hands, compared to its average volume of 321,563. Cooper Companies Inc has a 1 year low of $228.65 and a 1 year high of $344.32. The business has a fifty day moving average price of $291.59 and a 200-day moving average price of $309.79. The firm has a market capitalization of $14.65 billion, a P/E ratio of 25.80, a price-to-earnings-growth ratio of 2.14 and a beta of 0.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.29 and a quick ratio of 0.73.
Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, August 29th. The medical device company reported $3.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.16 by $0.07. The firm had revenue of $679.40 million during the quarter, compared to analyst estimates of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. Cooper Companies’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the company earned $3.00 EPS. As a group, equities analysts predict that Cooper Companies Inc will post 12.32 earnings per share for the current year.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Story: Google Finance
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.